相似文献
1
Role of the PP2A Pathway in Cholangiocarcinoma: State of the Art and Future Perspectives.
Cancers (Basel). 2022 Nov 3;14(21):5422. doi: 10.3390/cancers14215422.
2
Role of cantharidin in the activation of IKKα/IκBα/NF‑κB pathway by inhibiting PP2A activity in cholangiocarcinoma cell lines.
Mol Med Rep. 2018 Jun;17(6):7672-7682. doi: 10.3892/mmr.2018.8860. Epub 2018 Apr 5.
3
Liver transplantation for cholangiocarcinoma: Current status and new insights.
World J Hepatol. 2015 Oct 8;7(22):2396-403. doi: 10.4254/wjh.v7.i22.2396.
4
Cholangiocarcinoma: new perspectives for new horizons.
Expert Rev Gastroenterol Hepatol. 2021 Dec;15(12):1367-1383. doi: 10.1080/17474124.2021.1991313. Epub 2021 Nov 9.
5
Imaging Diagnosis of Intrahepatic and Perihilar Cholangiocarcinoma: Recent Advances and Challenges.
Radiology. 2018 Jul;288(1):7-13. doi: 10.1148/radiol.2018171187. Epub 2018 Jun 5.
6
Anatomical, histomorphological and molecular classification of cholangiocarcinoma.
Liver Int. 2019 May;39 Suppl 1:7-18. doi: 10.1111/liv.14093.
7
Translational Bioinformatics for Cholangiocarcinoma: Opportunities and Challenges.
Int J Biol Sci. 2018 May 22;14(8):920-929. doi: 10.7150/ijbs.24622. eCollection 2018.
8
Targeting as a New Potential Option for Intrahepatic Cholangiocarcinoma Treatment-Current State and Future Perspectives.
Molecules. 2020 Aug 18;25(16):3754. doi: 10.3390/molecules25163754.
9
Liquid biopsy in cholangiocarcinoma: Current status and future perspectives.
World J Gastrointest Oncol. 2021 May 15;13(5):332-350. doi: 10.4251/wjgo.v13.i5.332.
10
Cholangiocarcinoma: a site-specific update on the current state of surgical management and multi-modality therapy.
Chin Clin Oncol. 2020 Feb;9(1):4. doi: 10.21037/cco.2019.08.09. Epub 2019 Sep 2.
引用本文的文献
1
Circular RNA Vav3 mediated ALV-J inhibition of autophagy by modulating the gga-miR-375/CIP2A axis and activating AKT.
Poult Sci. 2025 Apr;104(4):104923. doi: 10.1016/j.psj.2025.104923. Epub 2025 Feb 17.
2
Cholangiocarcinoma Malignant Traits Are Promoted by Schwann Cells through TGFβ Signaling in a Model of Perineural Invasion.
Cells. 2024 Feb 20;13(5):366. doi: 10.3390/cells13050366.
3
A Novel Mouse Model of Combined Hepatocellular-Cholangiocarcinoma Induced by Diethylnitrosamine and Loss of .
Cancers (Basel). 2023 Aug 21;15(16):4193. doi: 10.3390/cancers15164193.
本文引用的文献
1
The MASTL-ENSA-PP2A/B55 axis modulates cisplatin resistance in oral squamous cell carcinoma.
Front Cell Dev Biol. 2022 Sep 28;10:904719. doi: 10.3389/fcell.2022.904719. eCollection 2022.
2
Current and emerging immunotherapeutic approaches for biliary tract cancers.
Hepatobiliary Pancreat Dis Int. 2022 Oct;21(5):440-449. doi: 10.1016/j.hbpd.2022.08.015. Epub 2022 Sep 7.
3
Cholangiocarcinoma: a review of the literature and future directions in therapy.
Hepatobiliary Surg Nutr. 2022 Aug;11(4):555-566. doi: 10.21037/hbsn-20-396.
4
LINC00665: An Emerging Biomarker for Cancer Diagnostics and Therapeutics.
Cells. 2022 May 4;11(9):1540. doi: 10.3390/cells11091540.
5
Protein phosphatase 2A regulates cytotoxicity and drug resistance by dephosphorylating AHR and MDR1.
J Biol Chem. 2022 May;298(5):101918. doi: 10.1016/j.jbc.2022.101918. Epub 2022 Apr 8.
6
Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study.
J Clin Oncol. 2022 Jun 20;40(18):2048-2057. doi: 10.1200/JCO.21.02568. Epub 2022 Mar 22.
7
How I treat biliary tract cancer.
ESMO Open. 2022 Feb;7(1):100378. doi: 10.1016/j.esmoop.2021.100378. Epub 2022 Jan 13.
8
Modified 5-aminolevulinic acid photodynamic therapy (M-PDT) inhibits cutaneous squamous cell carcinoma cell proliferation via targeting PP2A/PP5-mediated MAPK signaling pathway.
Int J Biochem Cell Biol. 2021 Aug;137:106036. doi: 10.1016/j.biocel.2021.106036. Epub 2021 Jul 2.
9
Long non-coding RNA LINC00665 promotes gemcitabine resistance of Cholangiocarcinoma cells via regulating EMT and stemness properties through miR-424-5p/BCL9L axis.
Cell Death Dis. 2021 Jan 12;12(1):72. doi: 10.1038/s41419-020-03346-4.
10
Higher content of microcystin-leucine-arginine promotes the survival of intrahepatic cholangiocarcinoma cells via regulating SET resulting in the poorer prognosis of patients.
Cell Prolif. 2021 Feb;54(2):e12961. doi: 10.1111/cpr.12961. Epub 2020 Nov 25.
Zotero 插件